Compounding is also permitted when commercially available medication is in short supply, which is exactly what happened early on with GLP-1 medications
Socioeconomic aspects of incretin-based therapy
Studies consistently show that even moderate weight loss, around 10% of body weight, can have meaningful benefits for sexual performance and overall sexual health
The first GLP-1 RA , exenatide (Byetta) was first approved by the FDA in 2009 as a twice-daily injectable, intended to be taken within an hour of morning and evening meals
"While on a GLP-1 medication, you may experience changes in hunger and even experience food aversions
On the GLP-1 front specifically, the FDA received hundreds of reports from patients who accidentally injected 5 to 20 times their intended dose because of concentration differences in compounded formulations